Secondary Logo

Editorial introductions

Section Editor(s): Harris, James C.; Sachdev, Perminder S.; Valenzuela, Michael

Current Opinion in Psychiatry: March 2019 - Volume 32 - Issue 2 - p v–vi
doi: 10.1097/YCO.0000000000000484

Current Opinion in Psychiatry was launched in 1988. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 13 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.

Back to Top | Article Outline


James C. Harris

Dr James C. Harris is the founding Director of the Developmental Neuropsychiatry program at the Johns Hopkins University School of Medicine and the Kennedy Krieger Institute and Professor of Psychiatry and Behavioral Sciences, Pediatrics, Mental Health, and History of Medicine, USA.

Dr Harris’ two volume single authored textbook, Developmental Neuropsychiatry, established the agenda for this emerging clinical specialty, garnering the Medical Book of the Year award from Doody's Health Science Books. He is series editor for Developmental Perspectives in Psychiatry for Oxford University Press US and writes the section on Developmental Neuropsychiatry for the Oxford Textbook of Psychiatry. In 1983, he founded the Autism Clinic at Johns Hopkins University School of Medicine. He received the George Tarjan Award for outstanding leadership and continuous contributions in the field of intellectual disability from the American Academy of Child and Adolescent Psychiatry, and is the recipient of the Agnes Purcell McGavin Award for Distinguished Career Achievement from the American Psychiatric Association in recognition of his pioneering work in developmental neuropsychiatry. In 2011, he received the Leon Eisenberg Award from Harvard Medical School, USA, for outstanding leadership and stewardship in the field of mental health and disabilities. He is the 2015 recipient of the Frank J. Menolascino Award for Psychiatric Services for Persons with Intellectual Developmental Disorders and the 2017 recipient of the American Academy of Child and Adolescent Psychiatry Catcher in the Rye Award for Life Time Steadfast Advocacy for Children with Psychiatric Disorders. His goal in working with children with neurodevelopmental disabilities has focused on helping each child to reach his or her individual potential believing, as he does, that all children are capable of personal self-expression and growth.

Back to Top | Article Outline

Perminder S. Sachdev

Perminder S. Sachdev, AM MBBS MD FRANZCP PhD FAHMS, is Scientia Professor of Neuropsychiatry, Co-Director of the Centre for Healthy Brain Ageing (CHeBA) in the School of Psychiatry, UNSW Sydney, Australia, and Clinical Director of the Neuropsychiatric Institute (NPI) at the Prince of Wales Hospital, Sydney, Australia. His major areas of research are drug-induced movement disorders, brain imaging, cognitive ageing and dementia. He has published over 600 peer-reviewed journal papers and six books, including one for lay readers (The Yipping Tiger and other tales from the neuropsychiatric clinic) and a book of poems (A migrant's musings). He was named NSW Scientist of the Year for biomedical sciences in 2010. In 2011, he was appointed Member of the Order of Australia (AM) for services to medical research. In 2018, he won the DARF-Yulgilbar Innovation Award for dementia research.

Back to Top | Article Outline

Michael Valenzuela

Michael Valenzuela BSc Hons, PhD, MBBS Hons, is Professor of Regenerative Medicine at the Sydney Medical School, Australia, and director of the Regenerative Neuroscience Group, Brain and Mind Centre, University of Sydney, Australia.

Michael studied psychology at the University of New South Wales (UNSW) in Sydney, Australia, before completing a PhD under the supervision of Professor Perminder Sachdev on the topic of cognitive reserve. For this work he was awarded the prestigious Eureka Prize for Medical Research in 2006. At the same time, he completed medical training at the University of Sydney and junior medical officer roles at the Prince of Wales Hospital, Australia. Since he was awarded a competitive Vice Chancellor's Fellowship from UNSW in 2006, he has received continuous National Health and Medical Research Council of Australia (NHMRC) funding, learning from and contributing to the labs of Professor Sachdev (neuropsychiatry), Professor Michael Breakspear (neuroimaging) and Dr Kuldip Sidhu (stem cells) at UNSW, and Professor Carol Brayne (public health) at Cambridge University, UK. In 2010 he was honoured to receive a NHMRC Excellence Award for the top-ranked clinical Career Development Fellow, and in 2012 established his own independent lab, the Regenerative Neuroscience Group, at the University of Sydney. In 2015 he received a NHMRC senior Career Development Fellowship, one of only six clinical fellowships awarded nationally.

Michael's research is uniquely multidisciplinary. His work on cognitive reserve is recognised internationally, including consultation to the upcoming WHO ICOPE Guidelines for cognition, writing the definitive entry for the Oxford Research Encyclopedia of Psychology and international advisory roles for the Barcelona Brain Health Initiative and Alzheimer Association Professional Interest Area on Cognitive Reserve and Resilience. He is senior advisor to the International Federation on Ageing for the inaugural multisectoral Cognitive Reserve Summit in Copenhagen in October 2019. His work in cognitive training includes some of the most widely cited systematic reviews, clinical trials and neuroimaging mechanistic studies, culminating in co-leadership of the Maintain Your Brain study in Australia, the world's largest dementia prevention trial. Michael's group has developed new technology for this trial, including a new platform for largescale deployment of cognitive training online and phone-based systems for memory assessment. Finally, Michael's group has patented a novel method of production of neural precursors from a patient's skin and recently established a new company to translate this exciting technology to human clinical trial for the treatment of dementia.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.